We present specific-heat and neutron-scattering results for the S =1/2 quantum antiferromagnet (dimethylammonium)(3,5-dimethylpyridinium)CuBr4. The material orders magnetically at T N =1.99(2) K, and magnetic excitations are accompanied by an energy gap of 0.30(2) meV due to spin anisotropy. The system is best described as coupled two-leg spin-1/2 ladders with the leg exchange J leg =0.60(2) meV, rung exchange Jrung=0.64(9) meV, interladder exchange Jint=0.19(2) meV, and an interaction-anisotropy parameter λ=0.93(2), according to inelastic neutron-scattering measurements. In contrast to most spin ladders reported to date, the material is a rare example in which the interladder coupling is very near the critical value required to drive the system to a Néel-ordered phase without an assistance of a magnetic field.
High-precision DC magnetization (M) measurements have been performed on a single crystal of copper pyrazine dinitrate (CuPzN) in magnetic fields H up to 14.7 T at temperatures down to 0.08 K. This material is one of the best realizations of a one-dimensional (1D) S = 1/2 Heisenberg antiferromagnet. At the base temperature, full saturation of M is observed above H s = 13.97 T with the M(H) curve closely following a prediction based on the Bethe ansatz. The peak in M(T ), which appears at about 7 K in zero field, moves to lower temperatures with increasing H and vanishes into a temperature region well below 0.08 K at H ∼ H s ; as a result, M(T ) exhibits a strong upturn as T → 0 at this field, in agreement with a theoretical prediction. These results constitute an observation of field-induced quantum critical behavior in bulk magnetization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.